Matthew Sorrentino to Risk Factors
This is a "connection" page, showing publications Matthew Sorrentino has written about Risk Factors.
Connection Strength
0.170
-
Lipid effects of antihypertensive medications. Curr Atheroscler Rep. 2012 Feb; 14(1):70-7.
Score: 0.041
-
Early intervention strategies to lower cardiovascular risk in early nephropathy: focus on dyslipidemia. Cardiol Clin. 2010 Aug; 28(3):529-39.
Score: 0.036
-
Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo. J Am Heart Assoc. 2026 02 03; 15(3):e46943.
Score: 0.027
-
Implications of the metabolic syndrome: the new epidemic. Am J Cardiol. 2005 Aug 22; 96(4A):3E-7E.
Score: 0.026
-
Cholesterol reduction to prevent CAD. What do the data show? Postgrad Med. 2000 Dec; 108(7):40-2, 45-6, 49-52.
Score: 0.019
-
Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role. Postgrad Med. 2000 Dec; 108(7):77-84.
Score: 0.019
-
Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesth Analg. 1994 Dec; 79(6):1133-40.
Score: 0.003